294 related articles for article (PubMed ID: 29541073)
41. CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.
Tang Q; Bluestone JA; Kang SM
J Mol Cell Biol; 2012 Feb; 4(1):11-21. PubMed ID: 22170955
[TBL] [Abstract][Full Text] [Related]
42. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
[TBL] [Abstract][Full Text] [Related]
43. T cell receptor repertoires after adoptive transfer of expanded allogeneic regulatory T cells.
Theil A; Wilhelm C; Kuhn M; Petzold A; Tuve S; Oelschlägel U; Dahl A; Bornhäuser M; Bonifacio E; Eugster A
Clin Exp Immunol; 2017 Feb; 187(2):316-324. PubMed ID: 27774628
[TBL] [Abstract][Full Text] [Related]
44. Regulatory T cells in stem cell transplantation: strategies and first clinical experiences.
Edinger M; Hoffmann P
Curr Opin Immunol; 2011 Oct; 23(5):679-84. PubMed ID: 21802270
[TBL] [Abstract][Full Text] [Related]
45. Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In Vivo.
Cooper ML; Choi J; Karpova D; Vij K; Ritchey J; Schroeder MA; DiPersio JF
J Immunol; 2017 May; 198(9):3746-3754. PubMed ID: 28330901
[TBL] [Abstract][Full Text] [Related]
46. Migratory properties of ex vivo expanded regulatory T cells: Influence of all-trans retinoic acid and rapamycin.
Beermann JL; Thiesler CT; Dringenberg U; Alter C; Kuhs S; Velaga S; Ukena SN; Franzke A
Transpl Immunol; 2017 Dec; 45():29-34. PubMed ID: 28870639
[TBL] [Abstract][Full Text] [Related]
47. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
Yang K; Fan ZP; Liu QF; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
[TBL] [Abstract][Full Text] [Related]
48. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
49. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
50. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
Vaeth M; Bäuerlein CA; Pusch T; Findeis J; Chopra M; Mottok A; Rosenwald A; Beilhack A; Berberich-Siebelt F
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1125-30. PubMed ID: 25583478
[TBL] [Abstract][Full Text] [Related]
51. Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer.
Wajant H; Beilhack A
Front Immunol; 2019; 10():2040. PubMed ID: 31555271
[TBL] [Abstract][Full Text] [Related]
52. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
[TBL] [Abstract][Full Text] [Related]
53. Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease.
Haribhai D; Chatila TA; Williams CB
Methods Mol Biol; 2016; 1422():197-211. PubMed ID: 27246035
[TBL] [Abstract][Full Text] [Related]
54. Umbilical cord blood-derived mesenchymal stem cells ameliorate graft-versus-host disease following allogeneic hematopoietic stem cell transplantation through multiple immunoregulations.
Wu QL; Liu XY; Nie DM; Zhu XX; Fang J; You Y; Zhong ZD; Xia LH; Hong M
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):477-484. PubMed ID: 26223913
[TBL] [Abstract][Full Text] [Related]
55. Manufacturing regulatory T cells for adoptive cell therapy in immune diseases: A critical appraisal.
Abhishek K; Nidhi M; Chandran S; Shevkoplyas SS; Mohan C
Clin Immunol; 2023 Jun; 251():109328. PubMed ID: 37086957
[TBL] [Abstract][Full Text] [Related]
56. A20 Restrains Thymic Regulatory T Cell Development.
Fischer JC; Otten V; Kober M; Drees C; Rosenbaum M; Schmickl M; Heidegger S; Beyaert R; van Loo G; Li XC; Peschel C; Schmidt-Supprian M; Haas T; Spoerl S; Poeck H
J Immunol; 2017 Oct; 199(7):2356-2365. PubMed ID: 28842469
[TBL] [Abstract][Full Text] [Related]
57. Donor regulatory T cells identified by FoxP3 expression but also by the membranous CD4+CD127low/neg phenotype influence graft-versus-tumor effect after donor lymphocyte infusion.
Hicheri Y; Bouchekioua A; Hamel Y; Henry A; Rouard H; Pautas C; Beaumont JL; Kuentz M; Cordonnier C; Cohen JL; Maury S
J Immunother; 2008; 31(9):806-11. PubMed ID: 18833007
[TBL] [Abstract][Full Text] [Related]
58. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
[TBL] [Abstract][Full Text] [Related]
59. Cell-Penetrating Anti-Protein Kinase C Theta Antibodies Act Intracellularly to Generate Stable, Highly Suppressive Regulatory T Cells.
Ozay EI; Shanthalingam S; Sherman HL; Torres JA; Osborne BA; Tew GN; Minter LM
Mol Ther; 2020 Sep; 28(9):1987-2006. PubMed ID: 32492367
[TBL] [Abstract][Full Text] [Related]
60. Ex vivo expansion of regulatory T cells for clinical applications against graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Zhang LF; Xia CQ
Chin Med J (Engl); 2013 Dec; 126(23):4575-82. PubMed ID: 24286428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
